文献速递食管与纵隔外科

经颈胸腺切除术是重症肌无力最具成本效益的手术方式

Transcervical Thymectomy Is the Most Cost-Effective Surgical Approach in Myasthenia Gravis.
PubMed 文献 · Ann Thorac Surg · 2020-03-02

该研究比较了胸骨切开、视频/机器人辅助和经颈三种胸腺切除术的围术期结局与费用。最终纳入25例经颈、23例视频/机器人辅助和14例胸骨切开患者。结果显示经颈胸腺切除术并发症率无差异,费用仅为胸骨切开的45%和视频/机器人辅助的58%,住院时间更短。

要点

  • 经颈胸腺切除术费用显著低于胸骨切开和视频/机器人辅助手术
  • 三种手术方式并发症率无差异
  • 经颈胸腺切除术住院时间最短

核心结论

  • 经颈胸腺切除术与更侵入性方式相比重症肌无力缓解率重叠,安全性相当且费用远低于胸骨切开和视频/机器人辅助方式。

研究设计与样本

  • 回顾性比较研究,排除肿瘤>4 cm或侵袭性肿瘤及非扩大胸腺切除术或合并手术患者,最终纳入25例经颈、23例视频/机器人辅助和14例胸骨切开患者。

主要发现

  • 经颈和胸骨切开组重症肌无力发生率更高(P < 0.001),视频/机器人辅助和胸骨切开组胸腺瘤发生率更高(P = .002)。
  • 胸骨切开组平均改良Charlson合并症评分(2.7 ± 2.1)高于经颈组(1.00 ± 0.58;P < .001)和视频/机器人辅助组(1.13 ± 0.97;P = .001)。
  • 三种手术方式并发症率无差异(P = 0.828)。
  • 经颈胸腺切除术费用为胸骨切开的45%(P < .001),为视频/机器人辅助的58%(P = .018),多因素分析差异仍显著。
  • 经颈胸腺切除术平均住院时间(1.2 ± 0.5天)短于胸骨切开(4.4 ± 3.5;P < .001)和视频/机器人辅助(2.4 ± 0.95;P = .045),床位费是费用差异的主要贡献因素。

临床怎么用

  • 对于符合条件的重症肌无力患者,经颈胸腺切除术可作为安全且更具成本效益的手术选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extended thymectomy has been proven to improve the course of myasthenia gravis. Retrospective studies demonstrate that several techniques for thymectomy achieve overlapping remission rates. We therefore compared perioperative outcomes and costs among 3 approaches to thymectomy: sternotomy, video and/or robot assisted, and transcervical. METHODS: To ensure similar study groups, we excluded patients with >4 cm or invasive tumors and those who underwent less than an extended thymectomy or concurrent procedures. Hospital costs were collected and analyzed by blinded finance personnel. RESULTS: The final study group consisted of 25 transcervical, 23 video/robot-assisted, and 14 sternotomy subjects. There was a higher incidence of myasthenia gravis in the transcervical and sternotomy groups (P < 0.001) and of thymoma in the video/robot-assisted and sternotomy groups (P = .002). Mean modified Charlson comorbidity score was higher for sternotomy (2.7 ± 2.1, mean ± SD) than transcervical (1.00 ± 0.58; P < .001) and video/robot-assisted (1.13 ± 0.97; P = .001) procedures. There was no difference in complication rates between approaches (P = 0.828). The cost of transcervical thymectomy was 45% of the cost of sternotomy (P < .001), and was 58% of the cost of video/robot-assisted (P = .018) approaches; these differences remained highly significant on multivariate analysis. Transcervical thymectomy had a shorter mean length of stay (1.2 ± 0.5 days) than median sternotomy (4.4 ± 3.5; P < .001), and video/robot-assisted thymectomy (2.4 ± 0.95; P = .045) and "bed cost" were major contributors to the cost difference between the groups. CONCLUSIONS: Transcervical thymectomy, which provides overlapping myasthenia gravis remission rates versus more invasive approaches, is equally safe and far less costly than sternotomy and video/robot-assisted approaches.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sholtis C, Teymourtash M, Berry M, et al. Transcervical Thymectomy Is the Most Cost-Effective Surgical Approach in Myasthenia Gravis. Ann Thorac Surg. 2020. PMID: 32135150. doi:10.1016/j.athoracsur.2020.01.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。